Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research
Figure 1 | Targeting epigenetics for cancer therapy | SpringerLink
Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy | Oncology
Frontiers | Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus | Cell and Developmental Biology
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells | Clinical Epigenetics | Full Text
Effects of HDAC inhibitors in cancer cells. In healthy cells, promoters... | Download Scientific Diagram
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed | Future Medicinal Chemistry
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect
Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines
Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization | IntechOpen
Known HAt inhibitors | Download Table
Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
HAT inhibitors and activators, their target histone acetyltransferases,... | Download Table
Cancers | Free Full-Text | Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer | HTML
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer | Future Oncology
HDAC and HAT activity toward DNA. HAT = histone acetyltransferase; HDAC... | Download Scientific Diagram
HAT inhibitors in cancer therapy - ScienceDirect
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo | Oncogenesis
Oxygen | Free Full-Text | Comprehension of the Relationship between Autophagy and Reactive Oxygen Species for Superior Cancer Therapy with Histone Deacetylase Inhibitors | HTML
Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology
Rational Combinations Using HDAC Inhibitors | Clinical Cancer Research
The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library
